Based on our regulatory knowledge, Expert Services identified the problems of a lense manufacturer and helped the japanese supplier of raw materials sort out their compliance issues.

Expert Services gained another important customer and is now registering monomers for this major Japanese supplier in Europe.

A worldwide rewarded pharmaceutical company was having problems getting an inhaler approved by FDA.

Based on our analytical expertise and regulatory knowledge, Expert Services identified the reasons for potential rejection by the FDA.

Subsequently, Expert Services has proposed modifications to the additive formulation in the plastic inhaler in order to meet the FDA requirements.